Bioengineering Partnerships with Industry (U01 Clinical Trial Optional)

Funding Agency:
National Institutes of Health

This Funding Opportunity Announcement (FOA) solicits applications from research partnerships formed by academic and industrial investigators to accelerate the development and adoption of promising bioengineering tools and technologies that can address important biomedical problems. The objectives are to establish these tools and technologies as robust, well-characterized solutions that fulfill an unmet need and are capable of enhancing our understanding of life science processes or the practice of medicine. Awards will focus on supporting multidisciplinary teams that apply an integrative, quantitative bioengineering approach to developing technologies. The goal of the program is to support technological innovations that deliver new capabilities which can realize meaningful solutions within 5 – 10 years.


  • Letter of Intent Due Date(s): 30 days prior to the application due date
  • Application Due Date(s): May 26, 2022; Sep 26, 2022; May 26, 2023; Sep 26, 2023; May 24, 2024; Sep 26, 2024
  • AIDS Application Due Dates: Sep 7, 2022; Jan 9, 2023; Sep 7, 2023; Jan 8, 2024; Sep 6, 2024; Jan 7, 2025

PAR-22-123 Expiration Date January 08, 2025




Engineering and Physical Sciences
Environmental & Life Sciences
Medical - Basic Science
Medical - Clinical Science
Medical - Translational

External Deadline

May 24, 2024